ALXO

ALX ONCOLOGY HLDGS INC

ALXO·00166B105·US·Common Stock·Healthcare - Biotechnology-Activist

ALXO (ALX ONCOLOGY HLDGS INC) is held by 45 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($26.1M), Blackstone Inc. ($11.7M), DRIEHAUS CAPITAL MANAGEMENT LLC ($11.5M). Net institutional sentiment: Bullish.

45
Holders
Avg rating(6 Elite)
$90.7M
Total Value
73% (51)
Fund Consensus
29 buying - 11 selling
ALXOSmart Money Verdict
View all
Held by 45 funds
6 elite
Who's Trading
ActivistLALSV Associates, LLC1.2%May 27, 2026
ActivistHHHBM Healthcare Investments (Cayman) Ltd.6.5%May 15, 2026
ActivistRERedmile Group, LLC6.8%May 15, 2026
ActivistIntegrated Core Strategies (US) LLCIntegrated Core Strategies (US) LLC0.5%Apr 28, 2026
InsiderLJLettmann JasonSell $27KMar 19, 2026
InsiderPSPinto ShellySell $2KMar 19, 2026
InsiderPSPinto ShellySell $1KFeb 18, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Feb 9, 2026
ActivistTCTCG Crossover GP II, LLC5.0%Feb 6, 2026
InsiderPSPinto ShellySell $4KJan 6, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
13M$26.1M0.3%+2.90%
47
New
5.8M$11.7M0.0%+2.90%
39
Increased
5.7M(+303.0%)$11.5M0.1%+10.40%
45
New
4.2M$8.4M0.0%+2.90%
38
Increased
3.8M(+141x)$7.5M0.0%+3.40%
44
New
2M$4M0.0%+2.90%
37
Decreased
2M(-38.0%)$4M0.0%+1.91%
0
Increased
1.6M(+148.0%)$3.2M0.0%-22.39%
43
Increased
1.3M(+779.9%)$2.7M0.0%+5.26%
42
New
950,550$1.9M0.0%+2.90%
36
Increased
914,754(+5.6%)$1.8M0.0%+55.30%
27
Increased
732,599(+73.2%)$1.5M0.0%+38.67%
38
Increased
577,783(+8.6%)$1.2M0.0%+49.41%
27
Increased
493,437(+39.5%)$989,7570.0%-89.00%
33
Decreased
447,799(-0.6%)$897,8360.0%+28.54%
0
New
294,478$590,4280.0%+2.90%
34
Increased
175,828(+41.5%)$352,5350.0%-74.29%
21
Increased
138,593(+702.9%)$277,8790.0%+5.50%
26
Decreased
136,964(-8.1%)$274,6130.0%-84.90%
0
New
107,647$215,8320.0%+2.90%
32

Showing 1-20 of 51

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used